stars 1 stars 2 stars 3

Bio-Nucleonics, is the only U.S. Company focused on the development and production of generic radiopharmaceuticals. It is approved by the U.S. Food and Drug Administration (FDA), the U.S. Nuclear Regulatory Commission, and the Florida Board of Pharmacy. The Company is experienced in the manufacturing of products in accordance with current Good Manufacturing Practice (cGMP) and Good Laboratory Practice (cGLP). Bio-Nucleonics is dedicated to improving the patient’s quality of life. We achieve this by developing and producing state-of-the-art radiopharmaceuticals, medical devices, and imaging agents. In today’s market, there’s a need for affordable, generic radiopharmaceuticals and diagnostic equipment. Our company is well-positioned to become a leader in this growth industry. The company is regulated by the U.S. Food and Drug Administration, the U.S. Nuclear Regulatory Commission, the Florida Bureau of Radiation Control, and the Florida Board of Pharmacy. Its products undergo rigorous validation and testing in accordance with current Good Manufacturing Practices, Good Laboratory Practices, and Quality System Requirements.

BioNucleonics, Inc Questions

The BioNucleonics, Inc annual revenue was $5 million in 2026.

Eva Capps is the Director of Marketing of BioNucleonics, Inc.

1 people are employed at BioNucleonics, Inc.

BioNucleonics, Inc is based in Doral, Florida.

The NAICS codes for BioNucleonics, Inc are [32541, 3254, 32, 325].

The SIC codes for BioNucleonics, Inc are [283, 28].

Top BioNucleonics, Inc Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users